In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Effect of lifelong physical activity on phenotype expression in hypertrophic cardiomyopathy

Session Poster Session 1

Speaker Vincent Aengevaeren

Congress : ESC Congress 2018

  • Topic : preventive cardiology
  • Sub-topic : Sports Cardiology, Other
  • Session type : Poster Session
  • FP Number : P664

Authors : V Aengevaeren (Nijmegen,NL), DHF Gommans (Nijmegen,NL), H-J Dieker (Nijmegen,NL), J Timmermans (Nijmegen,NL), FWA Verheugt (Nijmegen,NL), J Bakker (Dordrecht,NL), MTE Hopman (Nijmegen,NL), M-J De Boer (Nijmegen,NL), MA Brouwer (Nijmegen,NL), PD Thompson (Hartford,US), MJM Kofflard (Dordrecht,NL), GE Cramer (Nijmegen,NL), TMH Eijsvogels (Nijmegen,NL)

V. Aengevaeren1 , D.H.F. Gommans2 , H.-J. Dieker2 , J. Timmermans2 , F.W.A. Verheugt2 , J. Bakker3 , M.T.E. Hopman4 , M.-J. De Boer2 , M.A. Brouwer2 , P.D. Thompson5 , M.J.M. Kofflard6 , G.E. Cramer2 , T.M.H. Eijsvogels4 , 1Radboud University Medical Centre, Physiology/Cardiology - Nijmegen - Netherlands , 2Radboud University Medical Centre, Cardiology - Nijmegen - Netherlands , 3Albert Schweitzer Hospital, Radiology - Dordrecht - Netherlands , 4Radboud University Medical Centre, Physiology - Nijmegen - Netherlands , 5Hartford Hospital, Cardiology - Hartford - United States of America , 6Albert Schweitzer Hospital, Cardiology - Dordrecht - Netherlands ,

European Heart Journal ( 2018 ) 39 ( Supplement ), 93-94

Background: Hypertrophic cardiomyopathy (HCM) is characterized by inappropriate left ventricular (LV) wall thickness. Adaptations to exercise can occasionally mimic the HCM phenotype. However, it is unclear whether physical activity (PA) affects HCM genotype expression and disease characteristics.

Purpose: We aimed to 1) evaluate the effect of physical activity on genotype to phenotype transition and therefore we compared physical activity volumes between HCM gene carriers (G+) with a positive (P+) and negative (P-) HCM phenotype (G+/P+ versus G+/P-), and 2) we compared disease appearance and characteristics across tertiles of lifelong physical activity among HCM patients (G+/P+ and G-/P+).

Methods: HCM genotype positive individuals who were either HCM phenotype positive (G+/P+) or negative (G+/P-), as well as genotype negative HCM patients (G-/P+) were included. PA volumes were calculated as lifelong and pre-diagnosis average Metabolic Equivalent of Task (MET)-hrs/week. PA volumes were compared between G+/P+ and G+/P-participants. Secondly, clinical parameters of cardiac magnetic resonance imaging, echocardiography and Holter monitoring were compared across tertiles of PA volumes among all P+ participants.

Results: We included n=109 subjects (51±15 years, 51% male), including 44 G+/P+ HCM patients, 22 G+/P- HCM gene carriers, and 43 G-/P+ HCM patients without a (known) genetic mutation. PA volumes were not different (p=.33) between G+/P+ and G+/P- subjects. Secondly, there was no difference in LV function, LV morphology, LV wall thickness, LV mass, LGE, HighT2 presence and troponin levels across physical activity tertiles (all p>.05), but the most active HCM patients were younger at the time of diagnosis (tertile 1: 51±15 vs. tertile 2: 50±15 vs. tertile 3: 41±17 years, p=.045) and more often experienced non-sustained ventricular tachycardia on Holter monitoring (tertile 1: 4% vs. tertile 2: 31% vs. tertile 3: 28%, p=.03).

Conclusion: We found no differences in physical activity characteristics between HCM gene carriers with and without HCM phenotype. We also found no evidence of increased LV wall thickness, LV mass, HighT2 presence or elevated cardiac troponin levels among the most active HCM patients. However, the most active HCM patients were younger at the time of diagnosis and had a higher arrhythmic burden. These observations warrant further exploration of the role of exercise in HCM disease development.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are